Literature DB >> 25765579

High-yield production of vanillin from ferulic acid by a coenzyme-independent decarboxylase/oxygenase two-stage process.

Toshiki Furuya1, Misa Miura2, Mari Kuroiwa2, Kuniki Kino3.   

Abstract

Vanillin is one of the world's most important flavor and fragrance compounds in foods and cosmetics. Recently, we demonstrated that vanillin could be produced from ferulic acid via 4-vinylguaiacol in a coenzyme-independent manner using the decarboxylase Fdc and the oxygenase Cso2. In this study, we investigated a new two-pot bioprocess for vanillin production using the whole-cell catalyst of Escherichia coli expressing Fdc in the first stage and that of E. coli expressing Cso2 in the second stage. We first optimized the second-step Cso2 reaction from 4-vinylguaiacol to vanillin, a rate-determining step for the production of vanillin. Addition of FeCl2 to the cultivation medium enhanced the activity of the resulting E. coli cells expressing Cso2, an iron protein belonging to the carotenoid cleavage oxygenase family. Furthermore, a butyl acetate-water biphasic system was effective in improving the production of vanillin. Under the optimized conditions, we attempted to produce vanillin from ferulic acid by a two-pot bioprocess on a flask scale. In the first stage, E. coli cells expressing Fdc rapidly decarboxylated ferulic acid and completely converted 75 mM of this substrate to 4-vinylguaiacol within 2 h at pH 9.0. After the first-stage reaction, cells were removed from the reaction mixture by centrifugation, and the pH of the resulting supernatant was adjusted to 10.5, the optimal pH for Cso2. This solution was subjected to the second-stage reaction. In the second stage, E. coli cells expressing Cso2 efficiently oxidized 4-vinylguaiacol to vanillin. The concentration of vanillin reached 52 mM (7.8 g L(-1)) in 24 h, which is the highest level attained to date for the biotechnological production of vanillin using recombinant cells.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25765579     DOI: 10.1016/j.nbt.2015.03.002

Source DB:  PubMed          Journal:  N Biotechnol        ISSN: 1871-6784            Impact factor:   5.079


  7 in total

1.  Measurement of oxygen transfer from air into organic solvents.

Authors:  Hemalata Ramesh; Torsten Mayr; Mathias Hobisch; Sergey Borisov; Ingo Klimant; Ulrich Krühne; John M Woodley
Journal:  J Chem Technol Biotechnol       Date:  2015-12-29       Impact factor: 3.174

2.  Expression and characterization of a 9-cis-epoxycarotenoid dioxygenase from Serratia sp. ATCC 39006 capable of biotransforming isoeugenol and 4-vinylguaiacol to vanillin.

Authors:  Jiao Tang; Lei Shi; Lulu Li; Liangkun Long; Shaojun Ding
Journal:  Biotechnol Rep (Amst)       Date:  2018-04-18

3.  Proteomic Profiling, Transcription Factor Modeling, and Genomics of Evolved Tolerant Strains Elucidate Mechanisms of Vanillin Toxicity in Escherichia coli.

Authors:  Calum A Pattrick; Joseph P Webb; Jeffrey Green; Roy R Chaudhuri; Mark O Collins; David J Kelly
Journal:  mSystems       Date:  2019-06-11       Impact factor: 6.496

Review 4.  Strategies for the production of biochemicals in bioenergy crops.

Authors:  Chien-Yuan Lin; Aymerick Eudes
Journal:  Biotechnol Biofuels       Date:  2020-04-15       Impact factor: 6.040

5.  Maximizing the Efficiency of Vanillin Production by Biocatalyst Enhancement and Process Optimization.

Authors:  Francesca Luziatelli; Lorenza Brunetti; Anna Grazia Ficca; Maurizio Ruzzi
Journal:  Front Bioeng Biotechnol       Date:  2019-10-18

Review 6.  Bioprocess Optimization for the Production of Aromatic Compounds With Metabolically Engineered Hosts: Recent Developments and Future Challenges.

Authors:  Adelaide Braga; Nuno Faria
Journal:  Front Bioeng Biotechnol       Date:  2020-02-20

7.  Catabolic Machinery of the Human Gut Microbes Bestow Resilience Against Vanillin Antimicrobial Nature.

Authors:  Monika Yadav; Rajesh Pandey; Nar Singh Chauhan
Journal:  Front Microbiol       Date:  2020-10-16       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.